The fibroblast growth factor pathway is essential for inner ear induction in many 3 vertebrates, however how it regulates the chromatin landscape to coordinate the 4 activation of otic genes remains unclear. Here we show that FGF exposure of 5 sensory progenitors leads to rapid deposition of active chromatin marks H3K27ac 6 near hundreds of FGF-responsive, otic-epibranchial progenitor (OEP) genes, while 7
ABSTRACT 1 2 The fibroblast growth factor pathway is essential for inner ear induction in many 3 vertebrates, however how it regulates the chromatin landscape to coordinate the 4 activation of otic genes remains unclear. Here we show that FGF exposure of 5 sensory progenitors leads to rapid deposition of active chromatin marks H3K27ac 6 near hundreds of FGF-responsive, otic-epibranchial progenitor (OEP) genes, while 7 H3K27ac is depleted in the vicinity of non-otic genes. Genomic regions that gain 8
H3K27ac act as cis-regulatory elements controlling OEP gene expression in time and 9 space and define a unique transcription factor signature likely to control their activity. 10
Finally, we provide evidence that in response to FGF signalling the transcription 11 factor dimer AP1 recruits the histone acetyl transferase p300 to OEP enhancers and 12 that de novo acetylation is required for subsequent expression of OEP genes. Thus, 13 during ear induction FGF signalling modifies the chromatin landscape to promote 14 enhancer activation and chromatin accessibility. 15
The vertebrate inner ear is critical to relay auditory and vestibular information from 3 the environment to the brain. Developmental malformations or postnatal damage of 4 inner ear cells lead to permanent sensory defects as the ear does not have the ability 5 to regenerate or repair. Despite extensive studies, our understanding of normal ear 6 development has not yet translated into new biological approaches to alleviate such 7 disorders or to promote sensory cell regeneration in vivo. This is partly due to the 8 lack of mechanistic information downstream of signalling pathways that control ear 9 development and of how signalling events are translated into changes in gene 10 expression and cell behaviour. 11
The Fibroblast Growth Factor (FGF) pathway is crucially important for many steps 12 Here we study chromatin changes in response to FGF signalling during the 21 earliest step of ear development, the induction of otic-epibranchial progenitors. We 22 find that FGF stimulation of sensory precursors leads to deposition of H3K27ac 23 marks in the vicinity of ear-specific, FGF-response genes and that these genomic 24 regions act as ear-specific enhancers. De novo acetylation of H3K27 is required for 25 otic gene expression and fate allocation. We show that AP1 plays a key role in this 26 process: upon FGF signalling, AP1 recruits the histone acetylase p300 to ear 27 enhancers, which in turn promotes H3K27 acetylation associated with increased 28 chromatin accessibility and enhancer activation. Together these findings highlight 29 that during ear induction, the initial response to Erk/MAPK signalling directly 30 activates ear-specific enhancers, providing a molecular mechanism for rapid 31 activation of gene expression downstream of FGF. In turn, these observations may 32 impact on a variety of diseases and developmental disorders where FGFs play a 33 major role. Association of H3K27ac peaks to the nearest TSS reveals that genes 23 normally expressed in OEPs like the direct FGF targets Spry1 and Spry2, the FGF-24 responsive transcript Foxi3, the transcription factor Hesx1 and the chemokine Cxcl14 25 show a marked gain in H3K27ac (Figure 2A 
H3K27ac marks FGF-responsive enhancers in OEPs 1
Activation of gene expression is controlled by cis-regulatory elements and active 2 enhancers are normally flanked by H3K27ac peaks ( Figure 1C ) (for review see : 3 Maston et al., 2012 , Calo and Wysocka, 2013 , Kimura, 2013 . Therefore, the 4 increase in H3K27ac upon FGF stimulation may indicate the activation of ear 5 enhancers. To identify putative enhancers genome-wide, we extracted bimodal 6
H3K27ac peaks with a maximum distance of 3kb ( Figure 1D ) in sensory progenitors 7 (control) and FGF-induced OEPs; these are mostly located in intronic or intergenic 8 regions ( Figure 1E ). We find 2451 putative enhancers that are unique to control cells, 9 2883 specific to FGF2-treated progenitors, and 808 are common to both ( Figure 1F transcripts to those with putative active enhancers shows significantly higher 13 expression levels of the latter (Supplementary Figure 4 ). In addition, GO term 14 analysis confirms that putative enhancer associated genes are linked to terms like 15 inner ear development and MAP kinase signalling, while these terms are absent from 16 genes in controls ( Figure 1G ). 17
To assess whether the genomic regions flanked by H3K27ac are indeed 18 active OEP enhancers in vivo, we selected elements associated to known FGF 19 targets or OEP genes, cloned them into reporter constructs to drive eGFP and 20 assessed their activity in chick embryos. HH6 embryos were electroporated with 21 enhancer-eGFP vectors together with a control vector driving RFP ubiquitously. 22
There are four putative enhancers near Spry1, of which two were tested for in vivo 23 activity. Spry1-E2 is conserved across vertebrate species as determined by DREiVE 24 Figure 6 ). Therefore, H3K27ac enrichment in response to 1 FGF signalling identifies ear-specific enhancer regions. 2 3
Unique transcription factor motifs define OEP enhancers 4
Enhancers serve as transcription factor hubs that integrate different transcriptional 5 inputs to activate cell fate specific gene expression. To investigate whether a unique 6 transcriptional signature might regulate OEP genes, we performed motif enrichment. 7
Using RSAT matrix-scan we scanned for TF binding sites enriched in FGF2-treated 8 versus control cells and vice versa using JASPAR and TRANSFAC libraries to 9 identify known motifs. TFAP2 motifs ( Figure 3A and based on these data designed a NanoString probe set with 216 genes 23 containing 70 ear specific factors, as well as transcripts normally expressed in 24 progenitors for other sense organs, cranial ganglia, neural and neural crest cells. 25
Sensory progenitors from HH6 chick embryos were cultured in the absence or 26 presence of FGF2 for 3 and 6 hours and changes in gene expression were evaluated 27 by NanoString ( Figure 4A ). After 3 hrs known FGF targets (Etv4/5, Spry1/2) are 28 strongly up-regulated together with early OEP markers (e.g. Foxi3, Gbx2, Pax2, 29
Sox13 and Klf7; in total 16 otic TFs), while genes normally expressed in other cell 30 types (e.g. Pax6, Otx2, Msx1, Id2, -4) and some late otic genes (Sall4, Zfhx3, Fez1, 31 with an FGF-induced gain of H3K27ac ( Supplementary Figure 3, 4 ). Together, these 2 experiments suggest that FGF signalling initiates OEP induction by directly activating 3 enhancers of ear specific genes, and that this activity maybe mediated by AP1 4 together with other transcription factors. 5
AP1 recruits the histone acetyl-transferase p300 to ear-specific enhancers 6
What is the mechanism by which FGF and AP1 activate OEP enhancer regions? 7
Acetylation of H3K27 is mediated by histone acetyl-transferases (HAT) like p300. To 8 assess whether p300 occupies otic enhancers, we selected two experimentally 9 verified enhancers, Spry1-E1 and Foxi3-E1, with a significant gain of H3K27ac in 10 response to FGF activation. We electroporated p300-Flag into ear progenitors and 11 performed anti-Flag ChIP-qPCR from targeted tissue. Indeed, p300 is bound to both 12 enhancers, but is absent from the enhancer of the muscle gene MyoD ( Figure 5B ). 13
To test whether de novo acetylation is required for OEP gene expression we treated 14 sensory progenitors with FGF2 in the presence or absence of the p300 inhibitor 15 line with its FGF independence ( Figure 5A ). Using the general HAT inhibitor 20 anacardic acid has the same effect (data not shown). Therefore, de novo acetylation 21 of p300 targets is required for OEP gene expression. 22 23 AP1 is known to interact with p300 (Crish and Eckert, 2008), raising the 24 possibility that AP1 recruits p300 to OEP enhancers to facilitate histone acetylation. 25
To test this, we made use of a dominant negative form of Fos (acidic-Fos: a-Fos; 26 (Biddie et al., 2011), a truncated version of Fos that maintains its interaction with Jun, 27 but cannot bind DNA. HH6 chick embryos were electroporated with p300-Flag 28 together with a-Fos or RFP (control) constructs; targeted otic progenitors were 29 dissected and processed for ChIP-qPCR using anti-flag antibodies. While p300 30 binding to Spry1-E1 and Foxi3-E1 is observed in controls, this is inhibited in the 31 presence of a-Fos ( Figure 5B 
ChIP-seq data analysis 23
Sequence quality was assessed using FastQC (Andrews, 2010). During each ChIP-24 seq experiment, an amplification step was carried out that is reported to produce 25 mismatches at the first 9bp due to random priming (Adli and Bernstein, 2011). 26 Therefore, as the sequence quality was poor these 9bp were trimmed. Gao, Y., Cao, Q., Lu, L., Zhang, X., Zhang, Z., Dong, X., Jia, W., Cao, Y., 2015. Urness, L.D., Paxton, C.N., Wang, X., Schoenwolf, G.C., Mansour, S.L., 2010. FGF 34 signaling regulates otic placode induction and refinement by controlling both
